Cephalon Webcast aims to educate about opioid abuse
Biopharma company Cephalon is launching a national educational program about the importance of appropriate and responsible use of prescription opioid medications. The initiative, When Good Medicines Become Bad Drugs, will include a series of free educational programs, including a Webcast moderated the former director of the Office of National Drug Control Policy. According to the company, 71% of people who abuse prescription pain medicines received them from a friend or family member, not through a doctor's prescription. Earlier this month, Cephalon agreed to pay $425 million and enter a plea to resolve allegations of off-label marketing of the opioid Actiq and other drugs.